Ben Wheeler

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Myriad Genetics Inc publishes a filing, an earnings call transcript or a press release.

Get MYGN alerts

About Ben Wheeler

Ben Wheeler is recorded as CFO at Myriad Genetics Inc (MYGN). Ben Wheeler has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Myriad Genetics Inc on November 4, 2026. Myriad Genetics Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Myriad Genetics Inc includes R. Bryan Riggsbee (CEO), R. Bryan Riggsbee Chief (CEO), Sam Raha (CEO and Board Member) and 7 others.

Ben Wheeler on recent calls

“Let me start by reviewing our third quarter financial results. We reported revenue of $202.7 million of 6% sequentially and down 1% year-over-year.”

CFO, Q3 Earnings conference call (announced in 8-K) · November 4, 2026

“So from a timing standpoint, really, if I were to opine on why Q2 is the time that we encountered additional revenue cycle management friction, I'd be speaking on behalf of organizations that drove that friction, so it would just be a guess.”

CFO, Wells Fargo Healthcare Conference · September 10, 2026

“And welcome to the yearnings call team regarding the simplification.”

CFO, Myriad Genetics Inc Q1 FY2026 Earnings Call · May 5, 2026

“As Sam and Mark highlighted, we're seeing clear momentum from the operational and commercial progress made throughout 2025. Let me start with a recap of our fourth quarter growth drivers.”

CFO, Myriad Genetics Inc Q4 FY2025 Earnings Call · February 23, 2026

“I'm especially pleased to join you today as Myriad's Chief Financial Officer. Myriad is a company whose mission I've been fully committed to for the last 14 years, and it's an honor to now represent our team in this role.”

CFO, Myriad Genetics Inc Q3 FY2025 Earnings Call · November 3, 2025